AGTR1 and Hypertension: At present, we do not have experimental data with which we can explain why PHM did not lower the blood pressure in SHRSPs during the plateau phase of their hypertension development (that is, at ≥21 weeks of age), although it attenuated AT1R expression in RVLM astrocytes (Extended Data Fig. 10).